Contraceptive Agents, Female
"Contraceptive Agents, Female" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.
MeSH Number(s)
D27.505.696.875.360.276
D27.505.954.705.360.276
Concept/Terms
Contraceptive Agents, Female- Contraceptive Agents, Female
- Agents, Female Contraceptive
- Female Contraceptive Agents
- Contraceptives, Female
- Female Contraceptives
Below are MeSH descriptors whose meaning is more general than "Contraceptive Agents, Female".
Below are MeSH descriptors whose meaning is more specific than "Contraceptive Agents, Female".
This graph shows the total number of publications written about "Contraceptive Agents, Female" by people in Harvard Catalyst Profiles by year, and whether "Contraceptive Agents, Female" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 2 | 2 | 4 |
| 2007 | 1 | 1 | 2 |
| 2008 | 3 | 1 | 4 |
| 2009 | 2 | 1 | 3 |
| 2011 | 3 | 1 | 4 |
| 2012 | 3 | 3 | 6 |
| 2013 | 5 | 0 | 5 |
| 2014 | 1 | 1 | 2 |
| 2015 | 3 | 3 | 6 |
| 2016 | 7 | 3 | 10 |
| 2017 | 4 | 3 | 7 |
| 2019 | 9 | 1 | 10 |
| 2020 | 11 | 2 | 13 |
| 2021 | 5 | 1 | 6 |
| 2022 | 1 | 0 | 1 |
| 2023 | 4 | 0 | 4 |
| 2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Contraceptive Agents, Female" by people in Profiles.
-
Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial. BMC Womens Health. 2024 Mar 08; 24(1):167.
-
Continuation rates of hormonal intrauterine devices in adolescents and young adults when placed for contraceptive and non-contraceptive indications. Contraception. 2024 Jan; 129:110304.
-
Extending the use of levonorgestrel 52 mg intrauterine devices to 8 years. Am J Obstet Gynecol. 2023 07; 229(1):85.
-
Allergic and infectious complications of Etonogestrel implant placements: A case series. Contraception. 2023 06; 122:109994.
-
Contraceptive Implant-Associated Bleeding in Adolescent/Young Adult Clinical Practice: Associated Factors, Management, and Rates of Discontinuation. J Adolesc Health. 2023 04; 72(4):583-590.
-
Factors associated with never-use of long-acting reversible contraception among adult reproductive-aged women in Ohio. Perspect Sex Reprod Health. 2023 03; 55(1):38-48.
-
Method of Hormonal Contraception and Protective Effects Against Ectopic Pregnancy. Obstet Gynecol. 2022 05 01; 139(5):764-770.
-
Adolescent/Young Adult Long-Acting Reversible Contraception: Experience from a Multisite Adolescent Medicine Collaborative. J Pediatr. 2022 04; 243:158-166.
-
Racial disparities in reliable contraceptive use in women with heart disease. Eur J Contracept Reprod Health Care. 2022 Jun; 27(3):174-179.
-
The Association between Immediate Postpartum Depot Medroxyprogesterone Acetate Use and Postpartum Depressive Symptoms. Am J Perinatol. 2023 12; 40(16):1765-1769.